Who Owns PBE?

Invesco Biotechnology & Genome ETF — Institutional Ownership & 13F Holdings

$80.57

+0.00 (+0.00%)

Market Cap

$266.0M

Shares Outstanding

3,087,131

Institutional Holders

94

Total Inst. Value

$314.9M

% of Float Held

QoQ Holder Change

+15

Institutional data as of Q1 2025

New Positions

15

Closed Positions

10

Increased

15

Decreased

28

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO$241.6M3,808
2Gerber Kawasaki Wealth & Investment Management$15.5M243,959
3MORGAN STANLEY$12.2M192,853
4ROYAL BANK OF CANADA$4.8M75,402
5UBS Group AG$4.6M73,230
6WELLS FARGO & COMPANY/MN$4.6M72,611
7BANK OF AMERICA CORP /DE/$4.2M65,951
8GOLDMAN SACHS GROUP INC$2.4M37,657
9YHB Investment Advisors, Inc.$1.6M24,506
10One Capital Management, LLC$1.5M23,863

Biggest Buyers & Sellers This Quarter

Related Stocks

Frequently Asked Questions

How many institutional investors hold PBE?

As of Q1 2025, 94 institutional investors report holding PBE (Invesco Biotechnology & Genome ETF) in their 13F filings.

Which hedge fund owns the most PBE?

The largest institutional holder of PBE is NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO with $241.6M in shares.

Are institutions buying or selling PBE?

This quarter, 15 institutions opened new positions in PBE and 10 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.